Profilo
Sam J.
Milstein currently works at Cerus Endovascular Ltd., as Chairman and Cerus Endovascular, Inc., as Chairman.
Posizioni attive di Sam J. Milstein
| Società | Posizione | Inizio |
|---|---|---|
Cerus Endovascular Ltd.
 Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Presidente | - |
Cerus Endovascular, Inc.
 Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Cerus Endovascular Ltd.
Cerus Endovascular Ltd. Medical SpecialtiesHealth Technology Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Cerus Endovascular, Inc.
Cerus Endovascular, Inc. Medical SpecialtiesHealth Technology Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin. | Health Technology |
- Borsa valori
- Insiders
- Sam J. Milstein
